| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 314622 | Indenoisoquinoline derivative | 0.00140570135773563 | 0.10737742 |
| NSC 673803 | 9-Acridinamine, N-[3-[bis(2-hydroxyethyl)amino]propyl]- 7-methoxy-3-nitro- | 0.00140570135773563 | 0.5924049 |
| NSC 700913 | Null | 0.00140570135773563 | 0.6395192 |
| NSC 714187 | 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate | 0.00140570135773563 | 0.63959226 |
| NSC 715067 | Null | 0.00140570135773563 | 0.33250475 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.00159809164939554 | 0.53756079 |
| NSC 617076 | Free base of NSC 610966 | 0.00163780067775766 | 0.2842577 |
| NSC 753393 | 3-[2-(5-fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.00163780067775768 | 0.034769906 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00165587325865807 | 0.51269356 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.00165587325865807 | -0.04666573 |